Other Headlines

Advocacy groups applaud passage of bill that would permanently repeal and replace SGR.
The medical community pays tribute to a dedicated crew.
GI monitoring device promises to speed the evaluation and treatment of GI motility disorders.
A novel microfluidic drug delivery system makes it possible to reach parts of the body poorly served by oral and injectable medications.
DOTmed discusses the American Society for Therapeutic Radiation Oncology (ASTRO) program for public awareness with ASTRO's assistant director of communications, Beth Bukata.

Have News for Us?

Submit your news on the industry, people, or companies.

Forward to a Friend

More People & Company Headlines

Ceremony and Fund for Families of MedEvac Helicopter Crash The medical community pays tribute to a dedicated crew.

Ingestible Device Monitors GI Tract on the Go GI monitoring device promises to speed the evaluation and treatment of GI motility disorders.

Interview with Beth Bukata, Assistant Director of Communications for ASTRO DOTmed discusses the American Society for Therapeutic Radiation Oncology (ASTRO) program for public awareness with ASTRO's assistant director of communications, Beth Bukata.

iBrain Could Predict Drug Side Effects by Measuring Brainwaves A cell phone sized gadget could help predict drug side effects while even saying who's your twin -- just by recording brainwaves during sleep. Welcome to iBrain.

Nationwide Opens New Service Division Nationwide Imaging Services is now operating a new servicing and installation division, Nationwide Medical Equipment Services, LLC.

Stryker to Spend Almost $100 Million in New Acquisitions Stryker picks up Calif. software company OtisMed, and acquires assets behind Sonopet's ultrasonic aspirators.

The "Ratings Push" Is on That Will Choose The DOTmed 100 for 2010 -- The DOTmed 100 is a peer-evaluation program, so it's one of the truest measures of a company's commitment to integrity and customer satisfaction

Pacific Medical, LLC Expands Their Repair Facility Satisfied biomed customers and continued growth led to the move.

Genesis Magnet Services Celebrates Ten Years in Business A decade of MR quality from the independent service organization.

How Will Medicare Reform Impact Providers? A DOTmed Business News columnist comments on CMS and reform issues.

Gregory G. Germino, M.D.

Gregory G. Germino, M.D., Named Deputy Director of NIH's National Institute of Diabetes and Digestive and Kidney Diseases

by Barbara Kram, Editor
Gregory G. Germino, M.D., a world-renowned expert in inherited kidney disease, has been appointed as deputy director of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health, NIDDK Director Griffin P. Rodgers, M.D., has announced.

"Dr. Germino is a highly regarded physician-scientist, a committed mentor to the next generation of researchers, an experienced manager of budgets and people, and a compassionate communicator to professional and patient advocacy organizations," said Rodgers. "We are very fortunate to have him join us."

Germino, who was appointed in May, will help oversee an annual budget of $1.9 billion and a staff of 630 scientists, physician-scientists and administrators at NIDDK's research facilities in Bethesda, Md., and Phoenix. About 80 percent of the institute's budget goes into local economies to support research and research training at universities, institutions and medical centers throughout the United States. The NIDDK's research interests include common conditions such as diabetes and obesity and rare diseases such as sickle cell disease, Cooley's anemia and polycystic kidney disease, an inherited condition characterized by the development of cysts in the kidneys.

"I am honored to have been chosen as the deputy director of the NIDDK," said Germino. "NIDDK's history is distinguished, and I look forward to encouraging and contributing to its future."

As a research investigator at The Johns Hopkins University School of Medicine, where he was a professor of medicine in the Division of Nephrology and professor in the Department of Molecular Biology and Genetics, Germino made important contributions to understanding the genetic origins of polycystic kidney disease. In addition to the scientific and managerial leadership he will provide to the NIDDK, he will also continue his own research in polycystic kidney disease.

Germino is widely recognized as one of nephrology's premier scientists. His research has generated numerous high-quality antibodies, cell lines and cell culture systems and a series of genetically-altered mouse models that closely mimic human polycystic kidney disease. In the process, Germino has mentored more than 20 postdoctoral fellows, many of whom remain actively engaged in polycystic kidney disease research.

In 1979, Germino received his undergraduate degree in biology from Loyola University of Chicago and in 1983 received his medical degree from the Pritzker School of Medicine at the University of Chicago. In the same year, he began further training in internal medicine and nephrology at Yale and stayed on as a junior faculty member for another four years. He also spent a research year at Oxford University in England. Germino moved to The Johns Hopkins University in 1992 and became a full professor in 2003.

Germino has been a visiting professor and invited lecturer at universities, medical centers, and professional and nonprofit associations across the United States and around the world. He has authored more than 70 papers in peer-reviewed journals and more than a dozen book chapters. In addition, he has received numerous awards, including the NIH Physician-Scientist Award (1988-1993), the NIH MERIT Award (2000) and the Lillian Jean Kaplan International Prize for the Advancement in the Understanding of Polycystic Kidney Disease (2005). He has served on the boards of several national professional organizations.

NIDDK, part of NIH, conducts and supports basic and clinical research and research training on some of the most common, severe and disabling conditions affecting Americans. The Institute's research interests include: diabetes and other endocrine and metabolic diseases; digestive diseases, nutrition, and obesity; and kidney, urologic and hematologic diseases. For more information, visit www.niddk.nih.gov.

The National Institutes of Health (NIH) - The Nation's Medical Research Agency - includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

Please Send us your Comments.

Printable Story
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2009 DOTmed.com, Inc.
ALL RIGHTS RESERVED